Download presentation
Presentation is loading. Please wait.
Published byPernilla Bengtsson Modified over 6 years ago
1
Chemotherapy-Induced Neuropathy in Cancer Survivors
Christine Miaskowski, RN, PhD, Judy Mastick, RN, MN, Steven M. Paul, PhD, Kimberly Topp, PT, PhD, Betty Smoot, PT, DPTSc, Gary Abrams, MD, Lee-May Chen, MD, Kord M. Kober, PhD, Yvette P. Conley, PhD, Margaret Chesney, PhD, Kay Bolla, RN, BSN, Grace Mausisa, RN, MS, Melissa Mazor, RN, PhD(c), Melisa Wong, MD, Mark Schumacher, MD, PhD, Jon D. Levine, MD, PhD Journal of Pain and Symptom Management Volume 54, Issue 2, Pages e2 (August 2017) DOI: /j.jpainsymman Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions
2
Supplementary Fig. 1 Percentages of patients with (Y) and without (N) chemotherapy-induced neuropathy who felt each of the Semmes-Weinstein monofilaments at each of the sites tested in the upper extremities. Journal of Pain and Symptom Management , e2DOI: ( /j.jpainsymman ) Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions
3
Supplementary Fig. 2 Percentages of patients with (Y) and without (N) chemotherapy-induced neuropathy who felt each of the Semmes-Weinstein monofilaments at each of the sites tested on the dorsal surface of the lower extremities. Journal of Pain and Symptom Management , e2DOI: ( /j.jpainsymman ) Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions
4
Supplementary Fig. 3 Percentages of patients with (Y) and without (N) chemotherapy-induced neuropathy who felt each of the Semmes-Weinstein monofilaments at each of the sites tested on the plantar surface of the lower extremities. Journal of Pain and Symptom Management , e2DOI: ( /j.jpainsymman ) Copyright © 2017 American Academy of Hospice and Palliative Medicine Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.